CheckMan Stock Market Overview

From Carnival in Rio to truffle season in Tuscany, Silversea's newest sailings place guests at the heart of the world's most captivating cultural moments across 56 countries MIAMI, Oct. 6, 2026 /PRNewswire/ -- Silversea, the leading experiential luxury and expedition travel brand, has revealed new sailings within its Voyage Collection 2028-2029, 'Let the World Surprise You.' Itineraries are timed to the world's most captivating cultural moments, from Carnival in Venice and Rio de Janeiro to New Year's Eve in Funchal and Sydney, alongside new S.A.L.T.

Discover why Zacks initiated coverage of NODK with a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Learn how underwriting recovery, a stronger business mix and financial flexibility are offset by premium declines and catastrophe risk.

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- WHY:  Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public.

UNH heads into Q3 with investors focused on whether medical-cost gains can hold as Medicare Advantage margins improve without deeper member losses.

New subscription digital news brand will showcase reporting from local newsrooms in over 60 markets to a national audience New subscription digital news brand will showcase reporting from local newsrooms in over 60 markets to a national audience

New York, New York--(Newsfile Corp. - October 6, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hyliion Holdings Corp. ("Hyliion" or the "Company") (NYSE American: HYLN) on behalf of investors that purchased or otherwise acquired Hyliion securities between May 12, 2026 and June 23, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Hyliion and have suffered losses, you may CLICK HERE to contact us.

Biogen Inc (NASDAQ:BIIB, XETRA:IDP) is expected to report a slight third-quarter earnings per share beat at $2.14, against a consensus of $2.07, when it reports on October 28, says Jefferies. Revenue should be in line at $2.6 billion, with lower cost of goods sold and research and development expenses partly offset by higher selling, general and administrative costs.

Celsius Holdings (NASDAQ:CELH), the energy beverage company, is expected to report a 12% decline in third-quarter sales, and Jefferies says the results are unlikely to resolve questions over the brand's recovery. Jefferies expects the quarter to mark the bottom for Brand Celsius, with the focus shifting to when growth returns and how much it can accelerate as the company completes its product cleanup.

Delta Air Lines Inc (NYSE:DAL) faces a high bar for fourth-quarter revenue growth, with UBS saying investors are focused on whether the airline can offset a potential earnings guidance cut with stronger sales. Investors expect third-quarter revenue growth of about 16% to 16.5%, while expectations for earnings per share range from $1.70 to $1.90, compared with UBS's $1.70 estimate and a $1.94 consensus.

ARH (NYSE:RH)aus (NASDAQ: ARH (NYSE:RH)S) saw web traffic rise 84% year on year in September as Jefferies set a $12 price target, implying near 20% upside. Web traffic for the third quarter rose more than 60% year on year, an acceleration on both one-year and two-year bases, while engagement has stayed above average since Jefferies upgraded the shares in mid-September.